Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Learning the Language of Microbiological Control

Key Terms for Water Treatment Novices Water treatment specialists can forget that their clients may not understand the technical terms used in our industry. The language of microbiological control can be particularly confusing. To help establish a common working vocabulary, it’s important to define some key terms. Let’s get started! Types of Microorganisms Microorganisms are living…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Key Terms for Water Treatment Novices

Water treatment specialists can forget that their clients may not understand the technical terms used in our industry. The language of microbiological control can be particularly confusing. To help establish a common working vocabulary, it’s important to define some key terms. Let’s get started!

Types of Microorganisms

Microorganisms are living organisms that require high magnification to see because they are so small.

Bacteria are single cell microorganisms that require water, but not light, for normal grow. They are so small (0.5 to 5.0 micron) that it would take 200,000 to two million bacteria placed end to end to measure a yard. Under ideal conditions, bacteria populations can double every 15 minutes. There are over 10,000 distinct species of bacteria, many of which can cause serious problems in water systems.

Aerobic bacteria require oxygen for growth. Many types of aerobic bacteria can form thick, sticky biofouling deposits that can block water flow, reduce heat transfer, increase pumping costs, cause corrosion, and increase the potential for disease. These deposits are generically called slime, and result from bacteria forming protective biofilms on system surfaces.

Anaerobic bacteria require an absence of oxygen for growth. They can often be found growing underneath biofilms and biofouling deposits. Anaerobic bacteria including Sulfate Reducing Bacteria (SRB) are a major cause of microbiologically influenced corrosion (MIC) in water systems. Many anaerobic bacteria produce spores as a survival mechanism and can be cultivated from oxygenated water.

Protozoa are single cell microorganisms that can move independently, and feed on biofilm associated bacteria and waste products. Amoebae are a type of protozoa. Although microscopic, protozoa are typically 5 to 100 times larger than bacteria. The presence of protozoa in a water system indicates advanced microbiological growth associated with biofilms.

Legionella is a common waterborne bacteria that can cause a serious, sometimes fatal illness called Legionnaires’ disease in exposed individuals. It is caused by inhaling aerosolized droplets of water containing an infectious amount of Legionella bacteria. It is characterized by fever, chills, lung congestion, and severe pneumonia. The elderly, sick, immunocompromised, and smokers are most susceptible to develop Legionnaires disease upon exposure. Over 50 different species of Legionella have been identified. Only about half of the species have been associated with disease,

Colonization Characteristics

Microorganisms can be classified based on their colonization characteristics:

Planktonic bacteria are “free floating” in the bulk system water. Whether performed in a laboratory or in the field using dip slides, bacteria culture tests on water samples only measure planktonic bacteria counts.

Sessile bacteria are “surface attached” associated with biofilm deposits. Sessile bacteria are not detected by bulk water bacteria counts.

Biofilms are complex communities of surface attached bacteria growing inside a protective microbial secretion often called slime. Although biofilms start out microscopic in size, they can grow into visible biofouling deposits in just a matter of days. A wide range of problem causing microorganisms can grow to high levels protected within biofilms and associated microorganisms, especially amoebae. Once established, biofilms are difficult to remove and kill.

Extracellular Polymeric Substances (EPS) are microbial secretions that establish the foundation for biofilms and biofouling deposits. EPS secretions tightly bind biofilms to systems surfaces and protect growing microorganisms from environmental hazards including high level cleaner and biocide additions.

Biocides Types

Oxidizing biocides kill or inhibit bacteria growth by physically destroying cell structures. Chemical compounds that fall into this category are chlorine, bromine and peroxide.

Non-oxidizing biocides kill bacteria by interfering with essential metabolic processes, in effect poisoning the bacteria. Some common non-oxidizing biocides are glutaraldehyde and isothiazolin.

Sanitize, Disinfect, or Sterilize?

Although the exact definition will vary depending on the application, these terms refer to the relative effectiveness of processes for eradicating harmful microorganisms. The lowest level of cleaning and microbial control is sanitizing, following by disinfection, and then sterilization.

  • Sanitizing involves physical and chemical cleaning processes that reduce the number of microorganisms.
  • Disinfection involves adding disinfection chemicals in low-level, intermediate level or high-level control strategies.
  • Sterilization involves using chemicals, temperature, gas and/or pressure to kill or inactivate all disease-causing bacteria, spores, fungi and viruses

The First Step in Problem Solving

Understanding the terms used in the water treatment industry is always the first step in proper problem solving. Everyone working together on a problem must have the same basic knowledge of terms used in describing the conditions and the appropriate corrective tools. We will then be in a better position to achieve our common goal of maintaining clean cooling water systems that are free from uncontrolled microbiological growth.

Chem-Aqua provides custom water treatment solutions. We specialize in providing custom designed water treatment programs for boiler, cooling, and process water systems. We help our customers minimize their energy, water, and maintenance costs while ensuring safe and reliable operation of these critical systems.

Read more at chemaqua.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512